PubMed

Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus.

Henry RR.

Ann Intern Med. 1996 Jan 1;124(1 Pt 2):97-103. Review.PMID: 8554221 [PubMed - indexed for MEDLINE]Related articles

Type II diabetes mellitus.

Edelman SV.

Adv Intern Med. 1998;43:449-500. Review.PMID: 9506190 [PubMed - indexed for MEDLINE]Related articles

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.PMID: 15669880 [PubMed - indexed for MEDLINE]Related articles

Insulin therapy in type 2 diabetes.

Mudaliar S, Edelman SV.

Endocrinol Metab Clin North Am. 2001 Dec;30(4):935-82. Review.PMID: 11727406 [PubMed - indexed for MEDLINE]Related articles

Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.

Vinik A.

Clin Ther. 2007;29 Spec No:1236-53. Review.PMID: 18046925 [PubMed - indexed for MEDLINE]Related articles

Forum One: Current recommendations about intensification of metabolic control in non-insulin-dependent diabetes mellitus.

Henry RR, Genuth S.

Ann Intern Med. 1996 Jan 1;124(1 Pt 2):175-7.PMID: 8554214 [PubMed - indexed for MEDLINE]Related articles

Importance of glucose control.

Edelman SV.

Med Clin North Am. 1998 Jul;82(4):665-87. Review.PMID: 9706116 [PubMed - indexed for MEDLINE]Related articles

Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin.

Chan JL, Abrahamson MJ.

Mayo Clin Proc. 2003 Apr;78(4):459-67. Review.PMID: 12683698 [PubMed - indexed for MEDLINE]Related articlesFree article

Gycemic control, mealtime glucose excursions, and diabetic complications in type 2 diabetes mellitus.

Palumbo PJ.

Mayo Clin Proc. 2001 Jun;76(6):609-18. Review.PMID: 11393500 [PubMed - indexed for MEDLINE]Related articles

Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.

Yki-Järvinen H, Ryysy L, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Salo S, Seppälä P, Tulokas T, Viikari J, Taskinen MR.

J Clin Endocrinol Metab. 1997 Dec;82(12):4037-43.PMID: 9398709 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.

Porte D Jr.

Diabetes Metab Res Rev. 2001 May-Jun;17(3):181-8. Review.PMID: 11424231 [PubMed - indexed for MEDLINE]Related articles

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

[No authors listed]

Lancet. 1998 Sep 12;352(9131):837-53. Erratum in: Lancet 1999 Aug 14;354(9178):602. PMID: 9742976 [PubMed - indexed for MEDLINE]Related articles

Treatment of NIDDM with insulin agonists or substitutes.

Galloway JA.

Diabetes Care. 1990 Dec;13(12):1209-39. Review.PMID: 1980453 [PubMed - indexed for MEDLINE]Related articles

Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.

Emanuele N, Klein R, Abraira C, Colwell J, Comstock J, Henderson WG, Levin S, Nuttall F, Sawin C, Silbert C, Lee HS, Johnson-Nagel N.

Diabetes Care. 1996 Dec;19(12):1375-81.PMID: 8941467 [PubMed - indexed for MEDLINE]Related articles

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

Diabetes Care. 1998 Apr;21(4):574-9.PMID: 9571345 [PubMed - indexed for MEDLINE]Related articlesFree article

Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.

Yki-Järvinen H.

Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S77-81. Review.PMID: 12324990 [PubMed - indexed for MEDLINE]Related articles

Focus on insulin resistance in type 2 diabetes: therapeutic implications.

Reusch JE.

Diabetes Educ. 1998 Mar-Apr;24(2):188-93. Review.PMID: 9555358 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.

Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS.

Arch Intern Med. 1997 Jan 27;157(2):181-8.PMID: 9009975 [PubMed - indexed for MEDLINE]Related articles

Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial.

Tan M, Johns D, González Gálvez G, Antúnez O, Fabián G, Flores-Lozano F, Zúñiga Guajardo S, Garza E, Morales H, Konkoy C, Herz M; GLAD Study Group.

Clin Ther. 2004 May;26(5):680-93.PMID: 15220012 [PubMed - indexed for MEDLINE]Related articles

New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione.

Braunstein S.

Clin Ther. 2003 Jul;25(7):1895-917. Review.PMID: 12946541 [PubMed - indexed for MEDLINE]Related articles